| Bioactivity | MJN228 is a lipid-binding protein nucleobindin-1 (NUCB1) inhibitor with an IC50 of 3.3 μM[1]. |
| Target | NUCB1 |
| Invitro | MJN228 (25 μM) produces substantial reductions in lipid probe enrichment of NUCB1 in Neuro2a cells[1].MJN228 perturbs multiple lipid pathways in cells[1]. Western Blot Analysis[1] Cell Line: |
| Name | MJN228 |
| CAS | 459168-97-9 |
| Formula | C20H20N4O3 |
| Molar Mass | 364.40 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Niphakis MJ, et al. A Global Map of Lipid-Binding Proteins and Their Ligandability in Cells. Cell. 2015 Jun 18;161(7):1668-80. |